Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Markert

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Surgical Neurology|August 1, 1993
Paroxysmal bilateral dysosmia treated by resection of the olfactory bulbsJ M Markert, D O Hartshorn, S M Farhat
Neurosurgery|April 1, 1993
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovirJ M Markert, A Malick, D M Coen, et al.
Neurosurgery|February 1, 1996
Use of the extreme lateral approach in the surgical treatment of an intradural ventral cervical spinal cord vascular malformation: technical case reportJ M Markert, W F Chandler, J P Deveikis, et al.
Herpes : the Journal of the IHMF|February 28, 2002
Genetically engineered human herpes simplex virus in the treatment of brain tumoursJ M Markert, J N Parker, G Y Gillespie, et al.
Journal of Neurosurgery|October 1, 1992
Expanded spectrum of viral therapy in the treatment of nervous system tumorsJ M Markert, D M Coen, A Malick, et al.
Science (New York, N.Y.)|May 10, 1991
Experimental therapy of human glioma by means of a genetically engineered virus mutantR L Martuza, A Malick, J M Markert, et al.
Reviews in Medical Virology|February 2, 2000
Genetically engineered HSV in the treatment of glioma: a reviewJ M Markert, G Y Gillespie, R R Weichselbaum, et al.
AJNR. American Journal of Neuroradiology|May 1, 1995
Primary osseous amyloidoma causing spinal cord compressionH J Cloft, D J Quint, J M Markert, et al.
Gene Therapy|January 1, 1994
CNS tumor therapy by attenuated herpes simplex virusesT Mineta, J M Markert, Y Takamiya, et al.
Clinical Neuropathology|April 10, 2007
Necrotizing neurosarcoid: three cases with varying presentationsJ M Markert, K Powell, R S Tubbs, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Surgical Neurology|August 1, 1993
Paroxysmal bilateral dysosmia treated by resection of the olfactory bulbsJ M Markert, D O Hartshorn, S M Farhat
Neurosurgery|April 1, 1993
Reduction and elimination of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovirJ M Markert, A Malick, D M Coen, et al.
Neurosurgery|February 1, 1996
Use of the extreme lateral approach in the surgical treatment of an intradural ventral cervical spinal cord vascular malformation: technical case reportJ M Markert, W F Chandler, J P Deveikis, et al.
Herpes : the Journal of the IHMF|February 28, 2002
Genetically engineered human herpes simplex virus in the treatment of brain tumoursJ M Markert, J N Parker, G Y Gillespie, et al.
Journal of Neurosurgery|October 1, 1992
Expanded spectrum of viral therapy in the treatment of nervous system tumorsJ M Markert, D M Coen, A Malick, et al.
Science (New York, N.Y.)|May 10, 1991
Experimental therapy of human glioma by means of a genetically engineered virus mutantR L Martuza, A Malick, J M Markert, et al.
Reviews in Medical Virology|February 2, 2000
Genetically engineered HSV in the treatment of glioma: a reviewJ M Markert, G Y Gillespie, R R Weichselbaum, et al.
AJNR. American Journal of Neuroradiology|May 1, 1995
Primary osseous amyloidoma causing spinal cord compressionH J Cloft, D J Quint, J M Markert, et al.
Gene Therapy|January 1, 1994
CNS tumor therapy by attenuated herpes simplex virusesT Mineta, J M Markert, Y Takamiya, et al.
Clinical Neuropathology|April 10, 2007
Necrotizing neurosarcoid: three cases with varying presentationsJ M Markert, K Powell, R S Tubbs, et al.
Pageof 3